@article{TAU15047,
author = {Stacy Loeb and Caitlin Curnyn and Dawn Walter and Angela Fagerlin and Uwe Siebert and Nick Mühlberger and R. Scott Braithwaite and Mark D. Schwartz and Herbert Lepor and Erica Sedlander},
title = {Health state utilities among contemporary prostate cancer patients on active surveillance},
journal = {Translational Andrology and Urology},
volume = {7},
number = {2},
year = {2017},
keywords = {},
abstract = {Background: Active surveillance (AS) is the most rapidly expanding management option for favorable-risk prostate cancer (PCa). Early studies suggested substantial decrements in utility (quality of life weights) from disease-related anxiety. Our objective was to determine utilities for contemporary AS patients using different instruments.
Methods: We performed a systematic review of PubMed, PMC and OVID for utility measurements in modern AS patients. We then examined utilities among 37 men on AS participating in focus groups between 2015-2016 using the generic EurQol five dimensions questionnaire (EQ-5D-3L) and Patient Oriented Prostate Utility Scale (PORPUS), a PCa-specific instrument.
Results: The systematic review found previous studies with utilities for PCa treatment and historical watchful waiting populations, but none specifically in contemporary AS. In our AS population, the mean EQ-5D-3L score was 0.90±0.16 (median, 1.00; range, 0.21–1.00) and PORPUS was 0.98±0.03 (median, 0.99; range, 0.84–1.00). The Spearman correlation between the EQ-5D-3L and PORPUS was 0.87 (P0.1 between instruments.
Conclusions: Most contemporary AS patients had high utility scores suggesting that they perceive themselves in good health without a major decrement in quality of life from the disease. However, some patients had substantial differences in utility measured with generic versus disease-specific instruments. Further study is warranted into the optimal instrument for utility assessment in contemporary AS patients.},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/15047}
}